Forest Adds Icahn Director in Pact to Avoid Proxy Fight

Forest Laboratories Inc., the drugmaker that’s battled billionaire Carl Icahn in two proxy fights, added an Icahn representative to its board to avoid a third confrontation in as many years.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.